Apogee Therapeutics, Inc. (APGE)

Form 4 sales, Form 144 notices and lockup dates Biological Products, (No Diagnostic Substances), in Life sciences.

Sales chart range
Log in to watch APGE
Latest sale
$738k
Aug 5 · Routine
Form 4 sales
62
On record
Form 144 notices
34
Proposed sales
Sold, last 30 days
None
No Form 4 sale
Sold, last 90 days
None
No Form 4 sale
Next unlock
None
No lockup ahead

Lockups

None ahead
Every lockup on record has ended.
  1. LockupFrom the 424B4
    Jun 5, 2024 900 days ago

    90 days from Mar 7, 2024.

    424B4 on sec.gov

  2. IPO lockupAssumed date
    Jan 9, 2024 1048 days ago

    180 days after the closing. The prospectus also states 90 days.

    424B4 on sec.gov

Sales by reason

56
Routine
0
Plan not stated
1
No plan
5
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. Aug 5, 2026Routine

    Dambkowski Carl, Chief Medical Officer, sold 3.2% of their holdings

    $738k5,500 shares at $134.17

    Filed Aug 7, 2026Form 4

  2. Jul 8, 2026Routine

    Henderson Michael Thomas, Chief Executive Officer, sold 2% of their holdings

    $2.7M20,000 shares at $133.63

    Filed Jul 10, 2026Form 4

  3. Jul 1, 2026Routine

    Dambkowski Carl, Chief Medical Officer, sold 3% of their holdings

    $730k5,500 shares at $132.74

    Filed Jul 2, 2026Form 4

  4. Jul 1, 2026Notice

    Dambkowski Carl, Chief Medical Officer, filed a notice to sell 16,500 shares

    $2.2M16,500 shares

    Filed Jul 1, 2026Form 144

  5. Jun 22, 2026Unusual

    Dambkowski Carl, Chief Medical Officer, sold 12.8% of their holdings

    $3.5M26,400 shares at $132.60

    Filed Jun 24, 2026Form 4

  6. Jun 22, 2026Unusual

    Henderson Michael Thomas, Chief Executive Officer, sold 7.3% of their holdings

    $10.6M80,000 shares at $132.54

    Filed Jun 24, 2026Form 4

  7. Jun 22, 2026Notice

    Dambkowski Carl, Chief Medical Officer, filed a notice to sell 15,400 shares

    $1.4M15,400 shares

    Filed Jun 22, 2026Form 144

  8. Jun 22, 2026Notice

    Henderson Michael Thomas, Chief Executive Officer, filed a notice to sell 80,000 shares

    $10.6M80,000 shares

    Filed Jun 22, 2026Form 144

  9. Jun 10, 2026Routine

    Henderson Michael Thomas, Chief Executive Officer, sold 1.8% of their holdings

    $1.7M20,000 shares at $83.38

    Filed Jun 12, 2026Form 4

  10. Jun 3, 2026Routine

    Dambkowski Carl, Chief Medical Officer, sold 2.6% of their holdings

    $433k5,500 shares at $78.71

    Filed Jun 5, 2026Form 4

10 of 99

Every transaction

Every transaction on a Form 4 or Form 5 for APGE
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Sep 3, 2026Sep 3, 2026APGEMcKenna Mark C.DirectorReturned to the companyStock Option (Right to Buy)182,4880SEC
Sep 3, 2026Sep 3, 2026APGEMcKenna Mark C.DirectorReturned to the company20,0000SEC
Sep 3, 2026Sep 3, 2026APGEJones William A JrDirectorReturned to the companyStock Option (Right to Buy)32,4880SEC
Sep 3, 2026Sep 3, 2026APGEJones William A JrDirectorReturned to the company34,8240SEC
Sep 3, 2026Sep 3, 2026APGEDambkowski CarlChief Medical OfficerReturned to the companyStock Option (Right to Buy)319,3170SEC
Sep 3, 2026Sep 3, 2026APGEDambkowski CarlChief Medical OfficerReturned to the company168,498$1.10$186k0SEC
Sep 3, 2026Sep 3, 2026APGEFox Jennifer A.DirectorReturned to the companyStock Option (Right to Buy)32,4880SEC
Sep 3, 2026Sep 3, 2026APGEFox Jennifer A.DirectorReturned to the company34,8240SEC
Sep 3, 2026Sep 3, 2026APGEHenderson JaneChief Financial OfficerReturned to the companyStock Option (Right to Buy)383,9970SEC
Sep 3, 2026Sep 3, 2026APGEHenderson JaneChief Financial OfficerReturned to the company158,3710SEC
Sep 3, 2026Sep 3, 2026APGEBollinger LisaDirectorReturned to the companyStock Option (Right to Buy)48,7800SEC
Sep 3, 2026Sep 3, 2026APGEHenderson Michael ThomasChief Executive OfficerReturned to the companyStock Option (Right to Buy)997,0640SEC
Sep 3, 2026Sep 3, 2026APGEHenderson Michael ThomasChief Executive OfficerReturned to the company920,9410SEC
Sep 3, 2026Sep 3, 2026APGEShah Nimish PDirectorReturned to the companyNon-Voting Common Stock7.2M$126.73$911M0SEC
Sep 3, 2026Sep 3, 2026APGEShah Nimish PDirectorReturned to the company1.8M$135.11$236M0SEC
Sep 3, 2026Sep 3, 2026APGEFairmount Funds Management LLCDirectorReturned to the companyNon-Voting Common Stock6.8M0SEC
Sep 3, 2026Sep 3, 2026APGEFairmount Funds Management LLCDirectorReturned to the company443,1870SEC
Aug 7, 2026Aug 11, 2026APGEFairmount Healthcare Fund II L.P.DirectorExercised or settledStock Option (Right to Buy)42,2080SEC
Aug 7, 2026Aug 11, 2026APGEFairmount Healthcare Fund II L.P.DirectorExercised options42,208$23.60$996k340,855SEC
Aug 5, 2026Aug 7, 2026APGEDambkowski CarlChief Medical OfficerSold5,500$134.17$738k168,498SEC
Aug 5, 2026Aug 7, 2026APGEDambkowski CarlChief Medical OfficerExercised or settledStock Option (Right to Buy)4,125110,665SEC
Aug 5, 2026Aug 7, 2026APGEDambkowski CarlChief Medical OfficerExercised options4,125$22.86$94k173,998SEC
Jul 24, 2026Jul 24, 2026APGEHenderson JaneChief Financial OfficerGift15,000158,371SEC
Jul 14, 2026Jul 16, 2026APGEDambkowski CarlChief Medical OfficerGift8,000169,873SEC
Jul 10, 2026Jul 10, 2026APGEHenderson Michael ThomasChief Executive OfficerGift75,046920,941SEC
Jul 8, 2026Jul 10, 2026APGEHenderson Michael ThomasChief Executive OfficerSold20,000$133.63$2.7M995,987SEC
Jul 1, 2026Jul 2, 2026APGEDambkowski CarlChief Medical OfficerSold5,500$132.74$730k177,873SEC
Jul 1, 2026Jul 2, 2026APGEDambkowski CarlChief Medical OfficerExercised or settledStock Option (Right to Buy)4,125114,790SEC
Jul 1, 2026Jul 2, 2026APGEDambkowski CarlChief Medical OfficerExercised options4,125$22.86$94k183,373SEC
Jun 22, 2026Jun 24, 2026APGEDambkowski CarlChief Medical OfficerSold26,400$132.60$3.5M179,248SEC
Jun 22, 2026Jun 24, 2026APGEHenderson Michael ThomasChief Executive OfficerSold80,000$132.54$10.6M1MSEC
Jun 10, 2026Jun 12, 2026APGEHenderson Michael ThomasChief Executive OfficerSold20,000$83.38$1.7M1.1MSEC
Jun 9, 2026Jun 11, 2026APGEKiselak TomasDirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 9, 2026Jun 11, 2026APGEShah Nimish PDirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 9, 2026Jun 11, 2026APGEMcKenna Mark C.DirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 9, 2026Jun 11, 2026APGEJones William A JrDirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 9, 2026Jun 11, 2026APGEFox Jennifer A.DirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 9, 2026Jun 11, 2026APGEBollinger LisaDirectorAwardedStock Option (Right to Buy)7,6577,657SEC
Jun 3, 2026Jun 5, 2026APGEDambkowski CarlChief Medical OfficerSold5,500$78.71$433k205,648SEC
Jun 3, 2026Jun 5, 2026APGEDambkowski CarlChief Medical OfficerExercised or settledStock Option (Right to Buy)4,125118,915SEC
Jun 3, 2026Jun 5, 2026APGEDambkowski CarlChief Medical OfficerExercised options4,125$22.86$94k211,148SEC
May 13, 2026May 15, 2026APGEHenderson Michael ThomasChief Executive OfficerSold20,000$82.09$1.6M1.1MSEC
May 6, 2026May 8, 2026APGEDambkowski CarlChief Medical OfficerSold5,500$84.14$463k207,023SEC
May 6, 2026May 8, 2026APGEDambkowski CarlChief Medical OfficerExercised or settledStock Option (Right to Buy)4,125123,040SEC
May 6, 2026May 8, 2026APGEDambkowski CarlChief Medical OfficerExercised options4,125$22.86$94k212,523SEC
May 1, 2026May 4, 2026APGEHenderson JaneChief Financial OfficerSold2,000$82.04$164k173,371SEC
Apr 16, 2026Apr 20, 2026APGEHenderson Michael ThomasChief Executive OfficerExercised or settledStock Option (Right to Buy)3,000387,012SEC
Apr 16, 2026Apr 20, 2026APGEHenderson Michael ThomasChief Executive OfficerExercised options3,000$22.86$69k1.1MSEC
Apr 16, 2026Apr 17, 2026APGEHenderson JaneChief Financial OfficerSold2,000$90.00$180k175,371SEC
Apr 8, 2026Apr 10, 2026APGEHenderson Michael ThomasChief Executive OfficerSold20,000$82.58$1.7M1.1MSEC
Page 1

Sales, notices and lockups (99)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for APGE
Source
Aug 5, 2026Aug 7, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$738k3.2%RoutineSEC
Jul 8, 2026Jul 10, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$2.7M2.0%RoutineSEC
Jul 1, 2026Jul 2, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$730k3.0%RoutineSEC
Jul 1, 2026Jul 1, 2026Dambkowski CarlAPGEChief Medical OfficerForm 144 notice16,500$2.2MNoticeSEC
Jun 22, 2026Jun 24, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale26,400$3.5M12.8%UnusualSEC
Jun 22, 2026Jun 24, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale80,000$10.6M7.3%UnusualSEC
Jun 22, 2026Jun 22, 2026Dambkowski CarlAPGEChief Medical OfficerForm 144 notice15,400$1.4MNoticeSEC
Jun 22, 2026Jun 22, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 144 notice80,000$10.6MNoticeSEC
Jun 10, 2026Jun 12, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.7M1.8%RoutineSEC
Jun 3, 2026Jun 5, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$433k2.6%RoutineSEC
May 13, 2026May 15, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.6M1.8%RoutineSEC
May 13, 2026May 13, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 144 notice60,000$4.9MNoticeSEC
May 6, 2026May 8, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$463k2.6%RoutineSEC
May 6, 2026May 6, 2026Dambkowski CarlAPGEChief Medical OfficerForm 144 notice22,000$1.8MNoticeSEC
May 1, 2026May 4, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$164k1.1%RoutineSEC
May 1, 2026May 1, 2026Henderson JaneAPGEChief Financial OfficerForm 144 notice2,000$166kNoticeSEC
Apr 16, 2026Apr 17, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$180k1.1%RoutineSEC
Apr 8, 2026Apr 10, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.7M1.7%RoutineSEC
Apr 1, 2026Apr 3, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$467k2.6%RoutineSEC
Apr 1, 2026Apr 3, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$170k1.1%RoutineSEC
Mar 25, 2026Mar 27, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$170k1.1%RoutineSEC
Mar 25, 2026Mar 25, 2026Henderson JaneAPGEChief Financial OfficerForm 144 notice6,000$438kNoticeSEC
Mar 11, 2026Mar 13, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.5M1.7%RoutineSEC
Mar 4, 2026Mar 6, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$391k2.6%RoutineSEC
Mar 2, 2026Mar 4, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$140k1.1%RoutineSEC
Feb 11, 2026Feb 13, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.3M1.7%RoutineSEC
Feb 11, 2026Feb 11, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 144 notice60,000$3.8MNoticeSEC
Feb 4, 2026Feb 4, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale5,500$362k2.5%RoutineSEC
Feb 2, 2026Feb 4, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$132k1.1%RoutineSEC
Jan 22, 2026Jan 22, 2026Fairmount Funds Management LLCAPGEDirectorForm 144 notice1.8M$134MNoticeSEC
Jan 22, 2026Jan 22, 2026Harwin Peter EvanAPGEDirectorForm 4 sale1.8M$134M85.4%UnusualSEC
Jan 14, 2026Jan 16, 2026Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.6M1.6%RoutineSEC
Jan 7, 2026Jan 9, 2026Dambkowski CarlAPGEChief Medical OfficerForm 4 sale18,700$1.5M8.1%UnusualSEC
Jan 7, 2026Jan 7, 2026Dambkowski CarlAPGEChief Medical OfficerForm 144 notice35,200$2.8MNoticeSEC
Jan 6, 2026Jan 6, 2026Henderson JaneAPGEChief Financial OfficerForm 4 sale8,000$609k4.1%UnusualSEC
Jan 2, 2026Jan 2, 2026Henderson JaneAPGEChief Financial OfficerForm 144 notice12,000$906kNoticeSEC
Dec 19, 2025Dec 23, 2025Henderson JaneAPGEChief Financial OfficerForm 4 sale1,500$120k0.8%RoutineSEC
Dec 19, 2025Dec 19, 2025Henderson JaneAPGEChief Financial OfficerForm 144 notice1,500$116kNoticeSEC
Dec 10, 2025Dec 12, 2025Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.5M1.6%RoutineSEC
Dec 4, 2025Dec 5, 2025Dambkowski CarlAPGEChief Medical OfficerForm 4 sale10,900$818k3.9%RoutineSEC
Dec 4, 2025Dec 5, 2025Henderson JaneAPGEChief Financial OfficerForm 4 sale1,500$113k0.8%RoutineSEC
Dec 4, 2025Dec 5, 2025Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale40,000$3M3.1%RoutineSEC
Dec 4, 2025Dec 4, 2025Henderson JaneAPGEChief Financial OfficerForm 144 notice1,500$112kNoticeSEC
Dec 4, 2025Dec 4, 2025Dambkowski CarlAPGEChief Medical OfficerForm 144 notice10,900$813kNoticeSEC
Nov 25, 2025Nov 28, 2025Henderson JaneAPGEChief Financial OfficerForm 4 sale1,500$105k0.8%RoutineSEC
Nov 25, 2025Nov 25, 2025Henderson JaneAPGEChief Financial OfficerForm 144 notice1,500$102kNoticeSEC
Nov 14, 2025Nov 14, 2025Henderson JaneAPGEChief Financial OfficerForm 144 notice2,000$126kNoticeSEC
Nov 14, 2025Nov 14, 2025Henderson JaneAPGEChief Financial OfficerForm 4 sale2,000$130k1.0%RoutineSEC
Nov 13, 2025Nov 13, 2025Henderson Michael ThomasAPGEChief Executive OfficerForm 4 sale20,000$1.3M1.5%RoutineSEC
Nov 13, 2025Nov 13, 2025Henderson Michael ThomasAPGEChief Executive OfficerForm 144 notice100,000$6.7MNoticeSEC
Showing the first 50